
Riccardo Rinaldi
@riccardo_rin
MD • Interventional Cardiologist • Hospital Infermi, Rimini, Italy 🇮🇹 • PhD Program• University of the Sacred Heart • Rome, Italy 🇮🇹
ID: 1433829557933576192
03-09-2021 16:30:25
92 Tweet
558 Followers
425 Following



The ABCD score could avoid the need of ACh provocation testing in patients with a high score, reducing procedural risks, time, and cost, and allowing the implementation of a tailored treatment strategy 🔗atherosclerosis-journal.com/article/S0021-… Riccardo Rinaldi Rocco Montone EHJ Editor-in-Chief Giovanna Liuzzo


4 casos, 4 hospitales para aprender juntos a abordar diferentes anatomías. Iniciamos con bifurcaciones en una sesión de 1 hora on line con un caso grabado #CSCyoung Abierto para tod@s l@s que quieran aprender! clinic.zoom.us/webinar/regist… CSConline Prof. Hector M. Garcia-Garcia PCRonline 🫀 #EAPCI


• Acute PM2.5 exposure is assoc w/ an ⬆️ risk of plaque rupture as mechanism of 🫀 plaque instability • Mitigation strategies are crucial to ⬇️ the burden of ischemic heart disease, esp in patients w/ a ⬆️ risk of CV events Riccardo Rinaldi Rocco Montone 🔗 atherosclerosis-journal.com/article/S0021-…




Performing the ACh provocation test could be avoided in 👫 w/ a high score, especially if at increased risk of complications, substantially reducing procedural risks, time & cost 🔗atherosclerosis-journal.com/article/S0021-… Riccardo Rinaldi Rocco Montone EHJ Editor-in-Chief Giovanna Liuzzo


Useful tips from 18th #EBC consensus: - when multiple inflations, proximal-to-distal #POT to prevent stent elongation; - 'POT-puff sign' to check for adequate POT balloon diameter. - 'stent underdeployment' for #LM/#pLAD and significant size mismatch. EuroIntervention PCRonline 🫀


One-size does not fit all in ischemic heart disease 💔! Read our latest paper about Stratified and Precision medicine 💊 in ACS and CCS patients. Mattia Galli Tom Ford Juan Carlos Kaski Colin Berry EHJ Editor-in-Chief Riccardo Rinaldi #CardioTwitter #precisionmedicine 👉pdf.sciencedirectassets.com/272928/AIP/1-s…


Antithrombotic Therapy in ACS: which drug, when and for how long? thanks Riccardo Rinaldi & Andrea Ruberti for your great work! Hospital Clínic ACI-SEC: Hemodinamica PCRonline 🫀 TCTMD OPCI European Society of Cardiology authors.elsevier.com/a/1jZ267sv8qB4…



A patient-centered approach in management of stable angina, thank to Rocco Montone Riccardo Rinaldi for their coordinating central role in this very useful state-of-the-art review in JACC Journals Sici GISE Italo Porto FRANCESCO BURZOTTA Hospital Clínic jacc.org/doi/10.1016/j.…



Despite 2018 class IA endorsement of #DCB for #ISR, 2024 #CCS guidelines seem to softly favor DES. This shift is influenced by #DAEDALUS results, reporting that DCBs were less effective than repeat DES in DES-ISR. What do we expect from #RCT in de-novo lesions? Salvatore Brugaletta


This study highlights sex-related differences in acetylcholine testing, paving the way for personalized care in INOCA and MINOCA patients. #AHAJournals #GoRedforWomen #JAHASpotlight Riccardo Rinaldi Università Cattolica Rocco Montone ahajrnls.org/3FpJMhd


COVADIS criteria during acetylcholine testing provide prognostic insight in INOCA and MINOCA. Epicardial vasoconstriction emerges as a key risk indicator. Read the paper by Riccardo Rinaldi Rocco Montone here: 🔗 ow.ly/5Y9350VjOe5 #INOCA #MINOCA #Cardiology #COVADIS #EAPCI
